US 9,808,436 B2
Treatment of intrahepatic cholestatic diseases
Pol Boudes, Fremont, CA (US); and Charles A. McWherter, Oakland, CA (US)
Assigned to CymaBay Therapeutics, Inc., Newark, CA (US)
Filed by CymaBay Therapeutics, Inc., Newark, CA (US)
Filed on Sep. 21, 2016, as Appl. No. 15/271,460.
Application 15/271,460 is a continuation of application No. 14/663,027, filed on Mar. 19, 2015, granted, now 9,486,428.
Claims priority of provisional application 61/968,037, filed on Mar. 20, 2014.
Prior Publication US 2017/0014363 A1, Jan. 19, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/19 (2006.01); A61K 31/192 (2006.01); A61K 31/09 (2006.01)
CPC A61K 31/192 (2013.01) [A61K 31/09 (2013.01)] 9 Claims
1. A method of treating primary sclerosing cholangitis by administering to a subject in need thereof a therapeutically effective amount of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)-phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof.